ERBB2 and pancreatic adenocarcinoma: In accordance with Safran et al this study shows no consistent HER2 gene amplification in IHC +3 expressing pancreatic adenocarcinoma as seen in other cancers, suggesting some other pathways resulting in protein overexpression.